Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression - DocWire News

3/19/2022 12:00:00 AM3 years 1 month ago

Mol Cancer. 2022 Mar 18;21(1):77. doi: 10.1186/s12943-022-01547-3.ABSTRACTBACKGROUND: The use of epidermal growth factor receptor tyrosine kinase

Mol Cancer. 2022 Mar 18;21(1):77. doi: 10.1186/s12943-022-01547-3. ABSTRACT BACKGROUND: The use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) brings remarkable benefits… [+1778 chars]

full article...